{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-029407","form_type":"8-K","ticker":"ICCC","cik":"0000811641","company_name":"IMMUCELL CORP /DE/","filed_at":"2025-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.360968+00:00","generated_at":"2026-05-23T20:32:11.043389+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ImmuCell appoints Timothy C. Fiori as CFO effective April 7, 2025","bullets":["Fiori served 24 years at IDEXX Laboratories, most recently as Senior Director Finance, Commercial Operations.","Annual base salary set at $250,000; eligible for company benefit plans and 2017 Stock Option and Incentive Plan.","Incentive Compensation Agreement provides cash bonuses tied to attainment of specific objectives.","Press release dated April 7, 2025 furnished as Exhibit 99.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-029407","json":"https://secwatch.observer/filing/0001213900-25-029407.json","markdown":"https://secwatch.observer/filing/0001213900-25-029407.md","text":"https://secwatch.observer/filing/0001213900-25-029407.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/811641/000121390025029407/0001213900-25-029407-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/811641/000121390025029407/ea0237404-8k_immucell.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T20:32:11.043389+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6698ef6404","claim":"Timothy C. Fiori was elected as Chief Financial Officer at IMMUCELL CORP /DE/.","evidence_excerpt":"The Board of Directors of ImmuCell Corporation (the Company) has elected Timothy C. Fiori, age 46, to serve as its Chief Financial Officer effective April 7, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/811641/000121390025029407/0001213900-25-029407-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}